Voyager Therapeutics Inc (VYGR)

Precedente Chiudi:

$8.57

Aprire:

$8.65

Volume 24 ore:

651.61K

Capitalizzazione di mercato:

$469.37M

Reddito:

$250.01M

Utile/perdita netta:

$132.33M

Rapporto P/E:

3.8018

EPS:

2.27

Flusso di cassa netto:

$74.66M

1 W Prestazione:

+2.25%

1M Prestazione:

+8.15%

6M Prestazione:

+31.76%

1 anno Prestazione:

-24.07%

Intervallo 1D:

$8.30

$8.77

Portata 52W:

$6.06

$14.34

Voyager Therapeutics Inc Stock (VYGR) Company Profile

Nome

Voyager Therapeutics Inc

Settore

Healthcare (1211)

Industria

Biotechnology (697)

Telefono

857-259-5340

Indirizzo

75 Sidney Street, Cambridge, MA

Dipendente

88

Cinguettio

@VoyagerTx

Prossima data di guadagno

2024-06-05

Ultimi documenti SEC

VYGR's Discussions on Twitter

Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-05-10	Iniziato	Truist	Buy
2023-03-10	Iniziato	Oppenheimer	Outperform
2021-10-07	Aggiornamento	Robert W. Baird	Neutral → Outperform
2021-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2021-02-03	Downgrade	BTIG Research	Buy → Neutral
2021-02-03	Downgrade	Wedbush	Outperform → Neutral
2020-12-24	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-12-23	Downgrade	Raymond James	Outperform → Mkt Perform
2020-11-11	Downgrade	Oppenheimer	Outperform → Perform
2020-11-10	Downgrade	Raymond James	Strong Buy → Outperform
2020-11-10	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-03-19	Iniziato	The Benchmark Company	Buy
2020-02-06	Iniziato	Oppenheimer	Outperform
2018-11-15	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-09-10	Ripresa	BTIG Research	Buy
2018-09-10	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2018-06-04	Iniziato	H.C. Wainwright	Buy
2018-03-12	Downgrade	Evercore ISI	Outperform → In-line
2018-03-12	Downgrade	Wedbush	Outperform → Neutral
2018-02-02	Iniziato	Morgan Stanley	Overweight
2017-11-28	Ripresa	Piper Jaffray	Overweight
2017-10-31	Iniziato	Robert W. Baird	Outperform
2017-10-27	Iniziato	Canaccord Genuity	Buy
2017-10-23	Reiterato	Stifel	Buy
2017-10-12	Iniziato	Raymond James	Outperform
2017-08-17	Iniziato	Evercore ISI	Outperform
2017-07-28	Ripresa	Stifel	Buy

Mostra tutto

Voyager Therapeutics Inc Borsa (VYGR) Ultime notizie

Voyager Therapeutics (NASDAQ:VYGR) Rating Reiterated by HC Wainwright - MarketBeat

MarketBeat

Q2 2024 EPS Estimates for Voyager Therapeutics, Inc. Boosted by Analyst (NASDAQ:VYGR) - MarketBeat

MarketBeat

Wedbush Weighs in on Voyager Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:VYGR) - Defense World

Defense World

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the ... - GlobeNewswire

GlobeNewswire

Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease

GlobeNewswire Inc.

Voyager's journey to identify a new shuttle mechanism to bring gene therapies into the brain - BioCentury

BioCentury

Voyager Therapeutics Inc Azioni (VYGR) Dati Finanziari

Voyager Therapeutics Inc (VYGR) Reddito 2024

Voyager Therapeutics Inc (VYGR) Reddito netto 2024

Voyager Therapeutics Inc (VYGR) Flusso di cassa 2024

Voyager Therapeutics Inc (VYGR) Utile per azione 2024